Godavari Drugs opened lower at ₹116.55, compared with its previous close of ₹118.10. In the last trading session on 12 Nov 2026, the stock traded between ₹116.55 and ₹122.90, with an average traded price of ₹118.24. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Godavari Drugs is now worth
₹ 17,947.00
Giving a profit of
₹ 7,947.00 (79.47%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.10 (-0.08%)
Day High
₹122.90
Day Low
₹116.55
Day Open
₹116.55
Prev Close
₹118.10
Volume
1,754
Value Traded
₹0.02 Cr
1W Return
-1.13%
1M Return
-15.71%
3M Return
15.12%
6M Return
-7.09%
1Y Return
46.58%
Market Cap (₹ Cr.)
129
PE Ratio
31.00
PB Ratio
1.66
Dividend Yield
-
ROE
5.39%
ROCE
7.84%
Book Value (₹)
71.05
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.13%
6 Weeks
-
1 Month
-15.71%
3 Months
15.12%
9 Months
31.58%
No data available.
Godavari Drugs Q2FY27 Results: Net profit dips 4% YoY to ₹96 lakh
Standalone net profit for Q2FY27 declined 4.35% YoY to ₹95.72 lakh. Revenue from operations grew 5.91% YoY to ₹28.23 crore. Basic EPS dropped to ₹0.94 from ₹1.33 in the previous year due to dilution. Cash and cash equivalents fell to ₹3.33 crore amid heavy capex spending.
YesterdayGodavari Drugs board approves ₹340 million working capital limit from ICICI Bank
Godavari Drugs Ltd board approved working capital limits of ₹340 million from ICICI Bank. Facility terms are based on Credit Arrangement Letter dated October 12, 2026. Approval includes temporary overdraft facilities for exigencies and related security creation. Managing Director Mukund Kakani is authorized to execute facility and security documents. Borrowing is within limits approved by shareholders via Special Resolution in May 2022.
29 days agoGodavari Drugs AGM: All resolutions passed; nutraceuticals added
All four AGM resolutions passed with 99.96% votes in favour. Main objects clause altered to include nutraceuticals and dietary supplements. Ghanshyam Jaju re-appointed as director retiring by rotation. Cost auditor remuneration of ₹40,000 for FY27 ratified.
1mo agoGodavari Drugs seeks AGM nod for nutraceutical expansion on Sept 25
Godavari Drugs schedules 38th AGM for September 25, 2026. Shareholders to vote on MoA alteration for nutraceuticals business. Book closure runs from September 19 to September 25, 2026. E-voting window opens on September 22 and closes on September 24.
2mo agoGodavari Drugs reports no deviation in fund utilisation for Q1FY26
Godavari Drugs Limited confirmed no deviation in the use of ₹4,411.73 lakh raised via a March 2026 preferential issue. For Q1FY26, ₹763.27 lakh was utilised for capital expenditure related to API manufacturing infrastructure. No funds were deployed for working capital or loan repayment during the period.
2mo agoGodavari Drugs Q1FY26 net profit rises 7% YoY to ₹1.11 crore
Godavari Drugs Limited posted a 7% YoY net profit increase to ₹1.11 crore in Q1FY26, driven by 17% revenue growth to ₹28.00 crore. However, margins faced pressure as material costs surged 45% YoY. The company also completed a warrant conversion raising ₹5.25 crore and utilized ₹76.33 lakh for capex from its earlier preferential issue.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,898.50 | +0.72% | ₹4,55,513.74 | 41.20 | +9.61% | |
| ₹11,506.00 | +0.18% | ₹3,05,448.15 | 90.40 | +76.47% | |
| ₹4,689.50 | -0.80% | ₹1,78,373.51 | 85.50 | +22.61% | |
| ₹2,434.80 | +1.45% | ₹1,31,555.22 | 97.10 | +146.13% | |
| ₹1,204.60 | -0.12% | ₹1,20,159.31 | 28.00 | +26.61% | |
| ₹1,389.60 | +0.22% | ₹1,15,987.17 | 42.00 | +13.01% | |
| ₹1,409.00 | +0.05% | ₹1,13,827.26 | 39.90 | -7.26% | |
| ₹2,666.70 | +1.06% | ₹1,10,146.73 | 48.10 | +17.48% | |
| ₹1,815.40 | +0.45% | ₹1,04,454.10 | 26.00 | +53.38% | |
| ₹2,020.80 | +0.29% | ₹92,409.16 | 17.60 | -0.64% | |
| ₹2,643.30 | -0.62% | ₹74,600.45 | 51.60 | +43.05% | |
| ₹5,190.00 | -2.11% | ₹62,054.24 | 30.50 | -10.01% |
An investment of ₹10,000 made 5 years ago in Godavari Drugs is now worth
₹ 17,947.00
Giving a profit of
₹ 7,947.00 (79.47%)
Note: Past profits do not guarantee future returns.
